Request for Applications
The European Partnership for Personalised Medicine, EP PerMed, supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over 36.5 Mio. € (approx.).
Deadline:
The SAMRC is pleased to announce the release of a new funding opportunity by the US National Institutes of Health Research (NIH) under the U.S.-South Africa Program for Collaborative Biomedical Research – Phase 3 (HIV/AIDS). This is a jointly funded program between the SAMRC and the NIH and follows on from the successful Phase 1 and Phase 2 collaborative programs.